27 articles for thisTarget
The following articles (labelled with PubMed ID or TBD) are for your review
PMID
Data
Article Title
Organization
Short Hydrophobic Peptides with Cyclic Constraints Are Potent Glucagon-like Peptide-1 Receptor (GLP-1R) Agonists.
University of Queensland
Peptide inhibitors of the Escherichia coli DsbA oxidative machinery essential for bacterial virulence.
University of Queensland
Conformational selection of inhibitors and substrates by proteolytic enzymes: implications for drug design and polypeptide processing.
University of Queensland
Molecular engineering of conotoxins: the importance of loop size to alpha-conotoxin structure and function.
University of Queensland
Synthesis and in vitro evaluation of a library of modified endomorphin 1 peptides.
University of Queensland
Internalisation of the mu-opioid receptor by endomorphin-1 and leu-enkephalin is dependant on aromatic amino acid residues.
University of Queensland
Profiling the enzymatic properties and inhibition of human complement factor B.
University of Queensland
Enzyme adaptation to inhibitor binding: a cryptic binding site in phenylethanolamine N-methyltransferase.
University of Queensland
Antiproliferative and phenotype-transforming antitumor agents derived from cysteine.
University of Queensland
Hormone-like conopeptides - new tools for pharmaceutical design.
University of Queensland
Determining the necessity of phenyl ring π-character in warfarin.
University of Queensland
Low-molecular-weight peptidic and cyclic antagonists of the receptor for the complement factor C5a.
University of Queensland
Small molecular probes for G-protein-coupled C5a receptors: conformationally constrained antagonists derived from the C terminus of the human plasma protein C5a.
University of Queensland
Herbicide-binding sites revealed in the structure of plant acetohydroxyacid synthase.
University of Queensland
A refined agonist pharmacophore for protease activated receptor 2.
University of Queensland
Cyclic MrIA: a stable and potent cyclic conotoxin with a novel topological fold that targets the norepinephrine transporter.
University of Queensland
BENZODIAZEPINE DERIVATIVES USEFUL IN TREATING A RESPIRATORY SYNCYTIAL VIRUS INFECTION
Reviral
Unexpected novel binding mode of pyrrolidine-based aspartyl protease inhibitors: design, synthesis and crystal structure in complex with HIV protease.
Philipps-Universität Marburg